# Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein

> Research article (Neuro-Oncology, 2020) · cited 103× · AI/ML

**Wikidata**: [openalex:W3020913855](https://www.wikidata.org/wiki/openalex:W3020913855)  
**Source**: https://4ort.xyz/entity/entrectinib-a-trk-ros1-inhibitor-with-anti-cns-tumor-activity-differentiation-from-other-inhibitors-in-its-class-due-to-